← Back to Clinical Trials
Recruiting NCT07183475

NCT07183475 Return to Sports After Knee Arthroplasty

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07183475
Status Recruiting
Phase
Sponsor Technical University of Munich
Condition Knee Osteoarthristis
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-07-15
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Return to sports test

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-07-15 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The ability to return to sports after joint arthroplasty is increasingly becoming an important factor for patients in terms of their perceived quality of life. In sports orthopaedics, standardized functional tests have already been established - particularly for anterior cruciate ligament injuries - to assess athletic performance and prevent re-injury. These tests allow a stepwise evaluation of a subject's physical readiness for sports. In the field of arthroplasty, and despite increasing sports activity among patients with joint arthroplasty such structured assessment is still lacking. As a result, patients with arthroplasty typically resume sports activities based solely on individual recommendations from the surgeon or treating therapist. However, an objective evaluation of sports capability is currently not available. Therefore the amendment intends to expand the current testing protocol of the already registered and ongoing study (Protocol ID: UBonn\_TKA\_FollowUp) to include additional standardized, evidence-based return-to-sprort-tests.

Eligibility Criteria

Inclusion Criteria: * The study includes all patients with a history of unicondylar or bicondylar knee joint replacement and engagement in sports activity. * All participating patients have provided their informed consent following comprehensive information and explanation. * All participating patients have signed the informed consent form for study participation as well as the data protection declaration after receiving detailed information and clarification. Exclusion Criteria: * Patients who are unable to understand the patient information and study design (e.g., due to language barriers) or whose compliance is deemed insufficient by the study team * No knee joint endoprosthesis implanted * No engagement in athletic activity

Contact & Investigator

Central Contact

Christina Valle, Dr. med.

✉ christina.valle@tum.de

📞 004915142483500

Principal Investigator

Rüdiger von Eisenhart-Rothe, Univ. Prof. Dr. med.

STUDY CHAIR

Department of Orthopaedics and Sports Orthopaedics

Frequently Asked Questions

Who can join the NCT07183475 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Knee Osteoarthristis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07183475 currently recruiting?

Yes, NCT07183475 is actively recruiting participants. Contact the research team at christina.valle@tum.de for enrollment information.

Where is the NCT07183475 trial being conducted?

This trial is being conducted at Munich, Germany.

Who is sponsoring the NCT07183475 clinical trial?

NCT07183475 is sponsored by Technical University of Munich. The principal investigator is Rüdiger von Eisenhart-Rothe, Univ. Prof. Dr. med. at Department of Orthopaedics and Sports Orthopaedics. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology